AHL Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$7.07M Sell
115,364
-8,881
-7% -$555K 0.11% 350
2017
Q3
$7.92M Buy
124,245
+52,279
+73% +$3.05M 0.14% 249
2017
Q2
$4.01M Buy
71,966
+58,706
+443% +$3.19M 0.09% 423
2017
Q1
$721K Buy
+13,260
New +$727K 0.02% 876
2016
Q4
Sell
-6,851
Closed -$370K 1049
2016
Q3
$370K Buy
6,851
+1,016
+17% +$65.3K 0.01% 916
2016
Q2
$429K Buy
5,835
+2,149
+58% +$152K 0.02% 640
2016
Q1
$236K Sell
3,686
-22,647
-86% -$1.43M 0.01% 709
2015
Q4
$1.81M Buy
26,333
+18,215
+224% +$1.2M 0.14% 280
2015
Q3
$480K Sell
8,118
-67,934
-89% -$4.31M 0.08% 393
2015
Q2
$5.06M Sell
76,052
-6,777
-8% -$447K 0.2% 172
2015
Q1
$5.34M Buy
82,829
+37,777
+84% +$2.36M 0.21% 148
2014
Q4
$2.66M Buy
45,052
+39,554
+719% +$2.23M 0.14% 308
2014
Q3
$281K Buy
+5,498
New +$275K 0.02% 607

Other funds holding BMY